Egg White Supplementation in High-Intensity Functional Training
Effects of Egg White Supplementation on Body Composition, Physical Performance, and Amino Acid Profile of Individuals Undergoing High-intensity Functional Training
1 other identifier
interventional
40
1 country
1
Brief Summary
High-intensity functional training (HIFT), a new version of high-intensity interval training, has gained interest in recent years. HIFT is based on the CrossFit training template and includes multijoint movement patterns via both endurance and strengthening exercises. Research has shown positive effects of HIFT on body composition, cardiorespiratory fitness, and muscle performance of young individuals. The effectiveness of HIFT in higher ages and its protein requirements are less well documented. Protein requirements have been widely investigated in resistance training, where it has been found that protein supplementation may have additive beneficial effects on muscle strength and lean body mass. However, there is a research gap regarding the adaptations to HIFT when combined with protein supplementation. Thus, the aim of this research is to compare the effects of egg white supplementation, whey protein supplementation (as a positive comparator), and maltodextrin (a carbohydrate as placebo) on body composition, physical performance, and plasma amino acid profile in young and middle-aged trained individuals of both sexes who perform HIFT. Participants will take all three supplements for 6 weeks each, with 2 weeks of washout (no supplementation) in between, in random and counterbalanced order. Researchers will not know the supplementation status of the participants. Participants will receive 0.6 g of protein or placebo per kg body weight daily on top of isoenergetic dietary plans to avoid differences in energy intake that might compromise the validity of the study. The dietary plans will be individualized and will provided 1.0 g protein/kg body weight/day. The HIFT protocol will include multimodal patterns of movement, combining endurance and strengthening exercises with the use of equipment such as Total Resistance eXercise (TRX), Bosu, kettlebells, and barbells. Participants will undergo measurements of muscle strength, muscle endurance, aerobic capacity, and body composition at the beginning and end of the study, as well as during the two washout periods. Also, plasma amino acids, hematology, biochemistry, and hormones will be measured. Comparison of all these outcome measures between supplements will reveal whether protein supplementation is useful in HIFT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
April 26, 2022
CompletedFirst Posted
Study publicly available on registry
May 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedOctober 5, 2023
October 1, 2023
1.4 years
April 26, 2022
October 3, 2023
Conditions
Outcome Measures
Primary Outcomes (12)
Lean and fat mass pre-supplementation
Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.
Within 2 weeks before the beginning of supplementation.
Lean and fat mass post-supplementation
Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.
Within 2 weeks after the end of supplementation.
Maximal dynamic strength of shoulder muscles pre-supplementation
Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.
Within 2 weeks before the beginning of supplementation.
Maximal dynamic strength of shoulder muscles post-supplementation
Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.
Within 2 weeks after the end of supplementation.
Force-velocity relationship of knee flexors and extensors pre-supplementation
Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.
Within 2 weeks before the beginning of supplementation.
Force-velocity relationship of knee flexors and extensors post-supplementation
Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.
Within 2 weeks after the end of supplementation.
Plasma amino acid profile pre-supplementation
Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.
Within 4 days before the beginning of supplementation.
Plasma amino acid profile post-supplementation
Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.
Within 4 days after the end of supplementation.
Aerobic fitness pre-supplementation
Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.
Within 2 weeks before the beginning of supplementation.
Aerobic fitness post-supplementation
Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.
Within 2 weeks after the end of supplementation.
Muscle endurance pre-supplementation
Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions.
Within 2 weeks before the beginning of supplementation.
Muscle endurance post-supplementation
Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions.
Within 2 weeks after the end of supplementation.
Secondary Outcomes (16)
Biochemical analyses pre-supplementation
Within 4 days before the beginning of supplementation.
Biochemical analyses post-supplementation
Within 4 days after the end of supplementation.
Hormonal analyses pre-supplementation
Within 4 days before the end of supplementation.
Hormonal analyses post-supplementation
Within 4 days after the end of supplementation.
Resting metabolic rate pre-supplementation
Within 2 weeks before the beginning of supplementation.
- +11 more secondary outcomes
Study Arms (6)
Egg white - Whey protein - Maltodextrin
OTHERParticipants will receive egg white, whey protein, and maltodextrin in this order.
Egg white - Maltodextrin - Whey protein
OTHERParticipants will receive egg white, maltodextrin, and whey protein in this order.
Whey protein - Egg white - Maltodextrin
OTHERParticipants will receive whey protein, egg white, and maltodextrin in this order.
Whey protein - Maltodextrin - Egg white
OTHERParticipants will receive whey protein, maltodextrin, and egg white in this order.
Maltodextrin - Egg white - Whey protein
OTHERParticipants will receive maltodextrin, egg white, and whey protein in this order.
Maltodextrin - Whey protein - Egg white
OTHERParticipants will receive maltodextrin, whey protein, and egg white in this order.
Interventions
Intake of egg white
Intake of whey protein
Intake of maltodextrin
Eligibility Criteria
You may qualify if:
- Regular training (mixed endurance and resistance training 3 to 6 times a week, 50 min each session, for the past 4 months), as assessed by gym records or questionnaires
- Clearance from a pathologist or cardiologist to perform maximal exercise
- Mixed isoenergetic diet for the past 4 months
You may not qualify if:
- Smoking (even one cigarette or nicotine-containing device over the past 6 months)
- Any injuries to the musculoskeletal system that could interfere with the execution of training
- Chronic disease
- Egg allergy
- Milk allergy
- Pregnancy, lactation, or planning a pregnancy within the duration of the study
- Regular use of prescription medicine or supplements that might affect muscle function or recovery over the past month
- Intermittent or religious fasting
- Any vegetarian, ketogenic or protein diet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aristotle University Of Thessalonikilead
- European Commissioncollaborator
- Greek Ministry of Developmentcollaborator
Study Sites (1)
Laboratory of Evaluation of Human Biological Performance
Thessaloniki, 57001, Greece
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vassilis Mougios
Aristotle University Of Thessaloniki
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants are instructed not to disclose the supplement they are taking to their trainers, investigator, or outcome assessor.
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2022
First Posted
May 31, 2022
Study Start
November 1, 2021
Primary Completion
March 31, 2023
Study Completion
September 30, 2023
Last Updated
October 5, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share